FAQs | AREXVY (Respiratory Syncytial Virus Vaccine, Adjuvanted)

FAQs

Ask if AREXVY is right for you

FAQs

Ask if AREXVY is right for you

Questions to Ask Your Doctor or Pharmacist

Should I be concerned about respiratory syncytial virus (RSV)?
How could RSV impact me if I have asthma, chronic obstructive pulmonary disease (COPD), chronic heart failure (CHF), coronary artery disease (CAD), or diabetes?
Should I get vaccinated for RSV?
Is vaccination with AREXVY right for me?
How effective is vaccination with AREXVY?
What are the side effects of AREXVY?
When and where can I get vaccinated with AREXVY?

Find pharmacies near you that offer AREXVY

GET AREXVY

AREXVY FAQs

Collapse All Expand All

What is AREXVY?
AREXVY is an FDA-approved vaccine for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in:

people 60 years of age and older;

people 50 through 59 years of age at increased risk* for LRTD caused by RSV

*Increased risk includes people with conditions like respiratory, liver, cardiovascular, or kidney disease, or diabetes.
Why should someone who is 60+ years or who is 50-59 years at increased risk for RSV consider getting AREXVY?
AREXVY was proven effective in a large study with people 60+ years.

Over 82% EFFECTIVE in preventing lower respiratory disease from RSV in people aged 60 years and older

Over 94% EFFECTIVE in preventing lower respiratory disease from RSV in people aged 60 years and older with asthma, diabetes, chronic obstructive pulmonary disease (COPD), chronic heart failure (CHF), advanced liver or kidney disease, or any chronic respiratory/pulmonary disease

Effectiveness in adults 50-59 at increased risk* was based on the immune response compared to that seen in adults 60+.

*Increased risk includes people with conditions like respiratory, liver, cardiovascular, or kidney disease, or diabetes.
Who can get AREXVY?

AREXVY is available for people 60+ years and those 50-59 years at increased risk* for RSV.

*Increased risk includes people with conditions like respiratory, liver, cardiovascular, or kidney disease, or diabetes.
How is AREXVY given?

AREXVY is a single-dose injection (or “shot”) given in the upper arm.
What are the most common side effects of AREXVY?
The most common side effects of AREXVY are:

Pain, redness, and swelling at injection site

Fatigue

Muscle pain

Headache

Joint pain
Is vaccination with AREXVY covered by insurance?

The cost of vaccination with AREXVY depends on your age and the type of insurance you have. Ask your doctor or pharmacist if AREXVY is covered. If you need cost information, visit GSKforyou.com or call 1-866-GSK-FOR-U.

Have more questions about the vaccine?

ABOUT AREXVY

RSV FAQs

Collapse All Expand All

What is respiratory syncytial virus (RSV)?

RSV is a common and contagious respiratory virus. RSV infections can be severe and dangerous for certain people.
What factors and health conditions can put you at risk due to RSV?

Adults at highest risk for severe RSV include older adults and those with certain conditions such as asthma, diabetes, COPD, or CHF.
Why should I be concerned about RSV?

RSV is a contagious virus. The body’s immune system typically weakens with age and has a harder time fighting off infections, such as those from RSV. If you are an adult with certain health conditions, you may be at risk for severe infections from RSV. Ask your doctor about your risk.
Is it true that RSV infection can lead to pneumonia?

Yes, RSV infection can cause severe complications such as pneumonia.
Can RSV lead to hospitalization?

Yes, severe RSV infections can lead to hospitalization. If you are an adult with certain health conditions, you may be at risk for severe infections from RSV.
When is RSV season?
The seasonality of RSV can vary. Factors such as geographic location, population density, and even climate can impact RSV activity. But for the majority of the United States, RSV cases tend to:

Rise from mid-September to mid-November

Peak from late December to mid-February

Decline from mid-April to mid-May